Membrane protein-regulated networks across human cancers

Chun Yu Lin, Chia Hwa Lee, Yi Hsuan Chuang, Jung Yu Lee, Yi Yuan Chiu, Yan Hwa Wu Lee, Yuh Jyh Jong, Jenn Kang Hwang, Sing Han Huang, Li Ching Chen, Chih Hsiung Wu, Shih Hsin Tu, Yuan Soon Ho, Jinn Moon Yang

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

Alterations in membrane proteins (MPs) and their regulated pathways have been established as cancer hallmarks and extensively targeted in clinical applications. However, the analysis of MP-interacting proteins and downstream pathways across human malignancies remains challenging. Here, we present a systematically integrated method to generate a resource of cancer membrane protein-regulated networks (CaMPNets), containing 63,746 high-confidence protein–protein interactions (PPIs) for 1962 MPs, using expression profiles from 5922 tumors with overall survival outcomes across 15 human cancers. Comprehensive analysis of CaMPNets links MP partner communities and regulated pathways to provide MP-based gene sets for identifying prognostic biomarkers and druggable targets. For example, we identify CHRNA9 with 12 PPIs (e.g., ERBB2) can be a therapeutic target and find its anti-metastasis agent, bupropion, for treatment in nicotine-induced breast cancer. This resource is a study to systematically integrate MP interactions, genomics, and clinical outcomes for helping illuminate cancer-wide atlas and prognostic landscapes in tumor homo/heterogeneity.

原文英語
文章編號3131
期刊Nature Communications
10
發行號1
DOIs
出版狀態已發佈 - 十二月 1 2019

指紋

Membrane Proteins
cancer
membranes
proteins
Neoplasms
Tumors
resources
tumors
nicotine
Bupropion
Atlases
Biomarkers
Genomics
biomarkers
Nicotine
interactions
metastasis
breast
genes
Genes

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

引用此文

Lin, C. Y., Lee, C. H., Chuang, Y. H., Lee, J. Y., Chiu, Y. Y., Wu Lee, Y. H., ... Yang, J. M. (2019). Membrane protein-regulated networks across human cancers. Nature Communications, 10(1), [3131]. https://doi.org/10.1038/s41467-019-10920-8

Membrane protein-regulated networks across human cancers. / Lin, Chun Yu; Lee, Chia Hwa; Chuang, Yi Hsuan; Lee, Jung Yu; Chiu, Yi Yuan; Wu Lee, Yan Hwa; Jong, Yuh Jyh; Hwang, Jenn Kang; Huang, Sing Han; Chen, Li Ching; Wu, Chih Hsiung; Tu, Shih Hsin; Ho, Yuan Soon; Yang, Jinn Moon.

於: Nature Communications, 卷 10, 編號 1, 3131, 01.12.2019.

研究成果: 雜誌貢獻文章

Lin, CY, Lee, CH, Chuang, YH, Lee, JY, Chiu, YY, Wu Lee, YH, Jong, YJ, Hwang, JK, Huang, SH, Chen, LC, Wu, CH, Tu, SH, Ho, YS & Yang, JM 2019, 'Membrane protein-regulated networks across human cancers', Nature Communications, 卷 10, 編號 1, 3131. https://doi.org/10.1038/s41467-019-10920-8
Lin, Chun Yu ; Lee, Chia Hwa ; Chuang, Yi Hsuan ; Lee, Jung Yu ; Chiu, Yi Yuan ; Wu Lee, Yan Hwa ; Jong, Yuh Jyh ; Hwang, Jenn Kang ; Huang, Sing Han ; Chen, Li Ching ; Wu, Chih Hsiung ; Tu, Shih Hsin ; Ho, Yuan Soon ; Yang, Jinn Moon. / Membrane protein-regulated networks across human cancers. 於: Nature Communications. 2019 ; 卷 10, 編號 1.
@article{7516356b80cc487ca929a605fdd96362,
title = "Membrane protein-regulated networks across human cancers",
abstract = "Alterations in membrane proteins (MPs) and their regulated pathways have been established as cancer hallmarks and extensively targeted in clinical applications. However, the analysis of MP-interacting proteins and downstream pathways across human malignancies remains challenging. Here, we present a systematically integrated method to generate a resource of cancer membrane protein-regulated networks (CaMPNets), containing 63,746 high-confidence protein–protein interactions (PPIs) for 1962 MPs, using expression profiles from 5922 tumors with overall survival outcomes across 15 human cancers. Comprehensive analysis of CaMPNets links MP partner communities and regulated pathways to provide MP-based gene sets for identifying prognostic biomarkers and druggable targets. For example, we identify CHRNA9 with 12 PPIs (e.g., ERBB2) can be a therapeutic target and find its anti-metastasis agent, bupropion, for treatment in nicotine-induced breast cancer. This resource is a study to systematically integrate MP interactions, genomics, and clinical outcomes for helping illuminate cancer-wide atlas and prognostic landscapes in tumor homo/heterogeneity.",
author = "Lin, {Chun Yu} and Lee, {Chia Hwa} and Chuang, {Yi Hsuan} and Lee, {Jung Yu} and Chiu, {Yi Yuan} and {Wu Lee}, {Yan Hwa} and Jong, {Yuh Jyh} and Hwang, {Jenn Kang} and Huang, {Sing Han} and Chen, {Li Ching} and Wu, {Chih Hsiung} and Tu, {Shih Hsin} and Ho, {Yuan Soon} and Yang, {Jinn Moon}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41467-019-10920-8",
language = "English",
volume = "10",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Membrane protein-regulated networks across human cancers

AU - Lin, Chun Yu

AU - Lee, Chia Hwa

AU - Chuang, Yi Hsuan

AU - Lee, Jung Yu

AU - Chiu, Yi Yuan

AU - Wu Lee, Yan Hwa

AU - Jong, Yuh Jyh

AU - Hwang, Jenn Kang

AU - Huang, Sing Han

AU - Chen, Li Ching

AU - Wu, Chih Hsiung

AU - Tu, Shih Hsin

AU - Ho, Yuan Soon

AU - Yang, Jinn Moon

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Alterations in membrane proteins (MPs) and their regulated pathways have been established as cancer hallmarks and extensively targeted in clinical applications. However, the analysis of MP-interacting proteins and downstream pathways across human malignancies remains challenging. Here, we present a systematically integrated method to generate a resource of cancer membrane protein-regulated networks (CaMPNets), containing 63,746 high-confidence protein–protein interactions (PPIs) for 1962 MPs, using expression profiles from 5922 tumors with overall survival outcomes across 15 human cancers. Comprehensive analysis of CaMPNets links MP partner communities and regulated pathways to provide MP-based gene sets for identifying prognostic biomarkers and druggable targets. For example, we identify CHRNA9 with 12 PPIs (e.g., ERBB2) can be a therapeutic target and find its anti-metastasis agent, bupropion, for treatment in nicotine-induced breast cancer. This resource is a study to systematically integrate MP interactions, genomics, and clinical outcomes for helping illuminate cancer-wide atlas and prognostic landscapes in tumor homo/heterogeneity.

AB - Alterations in membrane proteins (MPs) and their regulated pathways have been established as cancer hallmarks and extensively targeted in clinical applications. However, the analysis of MP-interacting proteins and downstream pathways across human malignancies remains challenging. Here, we present a systematically integrated method to generate a resource of cancer membrane protein-regulated networks (CaMPNets), containing 63,746 high-confidence protein–protein interactions (PPIs) for 1962 MPs, using expression profiles from 5922 tumors with overall survival outcomes across 15 human cancers. Comprehensive analysis of CaMPNets links MP partner communities and regulated pathways to provide MP-based gene sets for identifying prognostic biomarkers and druggable targets. For example, we identify CHRNA9 with 12 PPIs (e.g., ERBB2) can be a therapeutic target and find its anti-metastasis agent, bupropion, for treatment in nicotine-induced breast cancer. This resource is a study to systematically integrate MP interactions, genomics, and clinical outcomes for helping illuminate cancer-wide atlas and prognostic landscapes in tumor homo/heterogeneity.

UR - http://www.scopus.com/inward/record.url?scp=85069431438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069431438&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-10920-8

DO - 10.1038/s41467-019-10920-8

M3 - Article

C2 - 31311925

AN - SCOPUS:85069431438

VL - 10

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 3131

ER -